Strengths
4baseCare is the pioneer of the world's first Indian population-specific cancer gene panel, enhancing treatment relevance for the local demographic.
The company offers a comprehensive 360-degree digital healthcare platform, OncoBuddy, which provides holistic support to cancer patients.
4baseCare integrates advanced genomic testing with digital health solutions, creating a seamless experience for patients and healthcare providers.
The focus on personalized cancer treatment through Next Generation Sequencing (NGS) positions 4baseCare as a leader in precision oncology.
Patient support programs that include psychological and dietary counseling address the holistic needs of cancer patients, improving overall care.
The empathetic and professional tone of communication fosters trust and rapport with patients and caregivers.
4baseCare's strong partnerships with notable organizations, such as Illumina, enhance its credibility and market reach.
The company has received significant funding, including a $6 million Series A round, which supports its growth and innovation initiatives.